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2.1. General Procedures 
Unless the reaction contained aqueous reagents or otherwise stated, all reactions were carried out under 
an atmosphere of argon, using oven dried glassware and standard techniques for handling air sensitive 
chemicals. 
Reagents were purified using standard laboratory procedures; benzene, dichloromethane and 
dichloroethane were distilled from CaH2 and stored under argon. THF and Et2O were distilled from 
potassium or sodium wire/benzophenone ketyl radical and stored under argon, 2,6-lutidine, DIPEA 
and Et3N were distilled from CaH2 and stored over CaH2 under argon. Solvents used for extraction and 
chromatography were distilled. All other chemicals were used as received from the supplier unless 
otherwise stated. Aqueous solutions of ammonium chloride (NH4Cl), sodium bicarbonate (NaHCO3), 
sodium thiosulfate (Na2S2O3), brine (NaCl) and sodium/potassium (Na/K) tartrate were saturated. 
Buffer solutions were prepared as directed from stock tablets. 
Flash column chromatography was carried out using Kieselgel 60 (230-400 mesh) and a positive solvent 
pressure. TLC was carried out using Merck Kieselgel 60 F254 plates, which were visualised under UV 
light (254 nm) and stained with potassium permanganate or phosphomolybdic acid/Ce2(SO4)3 dips. 
NMR spectra were recorded using the following machines: Bruker Avance II (600 MHz), Bruker Avance 
500 BB (500 MHz), Avance TCI cryoprobe (500 MHz) and Avance 400 DRX (400 MHz). 1H spectra 
were recorded at 298 K with an internal deuterium lock for the residual undeuterated solvent: CDCl3 
(δH = 7.26 ppm). 1H data are presented as: chemical shift (δ / ppm), relative to tetramethylsilane (δTMS = 
0 ppm), integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, qn = quintet, sext = 
sextet, sept = septet, m = multiplet, br = broad, app = apparent, obs = obscured) and coupling constants 
(J in Hz). Unless otherwise indicated, signals are assigned according to the numbering scheme for 
phormidolide A (vide infra). Assignments have been made based on 1D data presented along with 2D 
spectra and comparison with fully assigned spectra for similar compounds. 13C NMR spectra were 
recorded at 298 K with broadband proton decoupling and an internal deuterium lock for 13C: CDCl3 (δC 
= 77.0 ppm). Data are listed by chemical shift (δ/ppm) relative to tetramethylsilane (δTMS	=	0 ppm). 
Fourier transform IR spectroscopy (FT-IR) was carried out using a Perkin-Elmer Spectrum-One 
spectrometer and spectra were recorded as a thin film. Wavelengths of maximum absorption (νmax) are 
reported in wavenumbers (cm-1). Optical rotations were measured using a Perkin-Elmer 241 
polarimeter at the sodium D-line (589 nm) and are reported as [α]D
20, concentration (c in g/100 mL) and 
solvent used. High resolution mass spectrometry (HRMS) was carried out by the EPSRC National Mass 
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Spectrometry Facility (Swansea, UK) using electrospray ionisation (ESI). The parent ion [M+H]+, 
[M+NH4]+ or [M+Na]+ is quoted. Chiral HPLC was carried out on a Shimadzu XR-LC system, using a 
Chiralpak® IA column and a solvent system of mixed hexanes and isopropanol. 
The numbering system used for the carbon skeleton of phormidolide A follows that of Williamson et 
al.1, with the exception of skeletal substitutions (e.g. hydroxyl, methyl, methoxy and methylene groups), 
which are denoted by the skeletal carbon to which they are attached. The complete numbering scheme 
for phormidolide A (1) is shown below: 
 
Numbering scheme for the originally proposed structure of phormidolide A (1) 
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2.2. Synthesis of the C18-C23 vinyl iodide  
Alcohol – 4a 
 
AlMe3 (47.0 mL, 93.9 mmol) was added to a solution of Cp2ZrCl2 (1.95 g, 6.67 mmol) in CH2Cl2 (90 mL) 
at –20 °C. The solution was stirred for 10 min at –20 °C, before the addition of water (845 μL, 47.0 mmol). 
The pale-yellow suspension was stirred for 10 min at –20 °C. A solution of 3-butyn-1-ol (2.12 g, 30.3 
mmol) in CH2Cl2 (20 mL) was treated with AlMe3 (4.70 ml, 9.39 mmol) and transferred via cannula 
into the reaction. The reaction mixture was stirred for 16 h, with gradual warming to r.t., during which 
a yellow suspension formed. A solution of I2 (9.16 g, 36.4 mmol) in Et2O (200 mL) was transferred via 
cannula to the mixture at –20 °C, resulting in a colour change to vivid yellow, then brown. The reaction 
mixture was allowed to warm to r.t. and stirred for 2 h. The reaction was quenched by addition of Na/K 
tartrate (200 mL) and Et2O (200 mL) and vigorously stirred at r.t. for 1.5 h. The layers were separated, 
and the aqueous phase was extracted with Et2O (3 × 100 mL), dried (MgSO4) and the solvent removed 
under reduced pressure to afford a yellow liquid. Purification by flash column chromatography 
(Et2O/PE 30-40: 20%  30%) afforded the product 4a as a pale-yellow oil (5.22 g, 26.4 mmol, 87%). 
Rf (Et2O/PE 30-40: 50%) = 0.54; 1H NMR (400 MHz, CDCl3) dH 6.01 (1H, q, J = 1.0 Hz, H18), 3.72 (2H, 
t, J = 6.3 Hz, H21), 2.48 (2H, t, J = 6.3, H20), 1.87 (3H, s, Me19); 13C NMR (125 MHz, CDCl3) dC 144.5, 
76.8, 60.1, 42.4, 23.8.  
Data in agreement with that presented by Penner2 
Hydroxyester – 7 and ent-7 
 
Dess-Martin Periodinane (2.50 g, 5.89 mmol) was added to a stirred suspension of alcohol 4a (500 mg, 
2.35 mmol) and NaHCO3 (1.50 g, 17.8 mmol) in wet CH2Cl2 (25 mL). The reaction mixture was stirred 
at r.t. until TLC monitoring indicated full consumption of the starting material (ca. 1.5 h). The reaction 
was quenched by the addition of NaHCO3 (20 mL) and Na2S2O3 solution (20 mL) and stirred at r.t. for 
30 min. The layers were separated and the aqueous phase was extracted with CH2Cl2 (3 × 10 mL). The 
combined organic phases were washed with brine (50 mL), dried (MgSO4) and concentrated under 
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reduced pressure to ca. 10 mL. The solution of the crude aldehyde 4 was dried over 4 Å molecular sieves 
and directly used in the subsequent step without further purification. Aldehyde 4 was both volatile and 
highly prone to degradation, and an analytically pure sample was not obtained. 
BH3·SMe2 (279 µL, 2.95 mmol) was added dropwise to a stirred solution of N-tosyl-L-valine3 (799 mg, 
2.95 mmol) in CH2Cl2 (7 mL) and THF (1 mL) at 0 °C. The solution was stirred at 0 °C for 1 h before 
cooling to –78 °C. A combined solution of the crude aldehyde 4 and the silyl ketene acetal 54 (1.11 g, 
5.89 mmol, dried over CaH2) in CH2Cl2 (15 mL) was added via cannula to the reaction mixture. The 
reaction mixture was stirred at –78 °C for 3 h before quenching with NaHCO3 solution. Upon warming 
to r.t., the layers were separated and the aqueous phase extracted with CH2Cl2 (3 × 40 mL). The 
combined organic phases were washed with brine (100 mL), dried (MgSO4), and the solvent removed 
under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 5%) afforded 
the product 7 as an orange oil (516 mg, 3.95 mmol, 67% over 2 steps, 91% ee).  
The enantiomeric compound ent-7 was analogously prepared from alcohol 4a (1.00 g, 4.71 mmol), 
employing N-tosyl-D-valine (1.92 g, 7.07 mmol) as an orange oil (818 mg, 2.51 mmol, 53%) 
Rf (EtOAc/PE 40-60: 30%) = 0.57; 1H NMR (400 MHz, CDCl3) dH 6.02 (1H, q, J = 0.9 Hz, H18), 4.16 
(2H, q, J = 7.1 Hz, CH3CH2O), 3.81 (1H, ddd, J = 10.0, 5.6, 2.5 Hz, H21), 2.39 (1H, d, J = 5.6 Hz, OH), 
2.33 (1H, br d, J = 13.2 Hz, H20a), 2.26 (1H, dd, J = 13.9, 10.0 Hz, H20b), 1.90 (3H, d, J = 0.9 Hz, Me19), 
1.27 (3H, t, J = 7.1 Hz, CH3CH2O), 1.20 (3H, s, Me22a), 1.20 (3H, s, Me22b); 13C NMR (125 MHz, CDCl3) 
dC 177.1, 145.1, 73.7, 60.8, 46.7, 42.0, 23.9, 21.6, 20.7, 14.2, 14.1; IR (thin film): νmax 3526, 2984, 1716, 
1469, 1386, 1269, 1134, 1070; [α]D
20 +13.9 (7, c 1.0, CHCl3); [α]D
20 -12.6 (ent-7, c 0.26, CHCl3); Chiral 
HPLC (Chiralpak® IA, iPrOH : n-hexane: 5%) RT (major) 10.02 min, RT (minor) 10.74 min; HRMS (ESI+) 
calculated for C11H20O3I [M+H]+ 327.0452, found 327.0451. 
TES ether – 7a and ent-7a 
 
2,6-Lutidine (128 µL, 1.10 mmol) was added to a stirred solution of hydroxyester 7 (240 mg, 0.736 mmol) 
in CH2Cl2 (8 mL). The reaction mixture was cooled to –78 °C and stirred for 5 min, before the dropwise 
addition of TESOTf (208 µL, 0.920 mmol). The mixture was stirred at –78 °C for 45 min, before 
quenching with NaHCO3 solution (10 mL). Upon warming to r.t., the layers were separated and the 
aqueous phase extracted with CH2Cl2 (3 × 10 mL). The combined organic phases were washed with 
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brine (15 mL), dried (MgSO4) and the solvent removed under reduced pressure. Purification by flash 
column chromatography (EtOAc/PE 40-60: 10%) afforded the product 7a as a colourless oil (319 mg, 
0.721 mmol, 98%).  
The enantiomeric compound ent-7a was analogously prepared from hydroxyester ent-7 (818 mg, 2.51 
mmol) as a colourless oil (1.01 g, 2.29 mmol, 91%) 
Rf (EtOAc/PE 40-60: 30%) = 0.80; 1H NMR (500 MHz, CDCl3) dH 5.93 (1H, q, J = 1.0 Hz, H18), 4.15-
4.08 (3H, m, MeCH2O, H21), 2.27 (1H, dd, J = 13.7, 7.9 Hz, H20a), 2.21 (1H, dd, J = 13.5, 3.4 Hz, H20b), 
1.84 (3H, d, J = 1.0 Hz, Me19), 1.26 (3H, t, J = 7.1 Hz, MeCH2), 1.17 (3H, s, Me22a), 1.09 (3H, s, Me22b) 
0.94 (9H, t, J = 8.0 Hz, Si(CH2CH3)3), 0.57 (6H, q, J = 8.0 Hz, Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) 
dC 176.7, 144.5, 78.3, 74.3, 60.4, 48.0, 44.6, 23.8, 22.9, 17.8, 14.1, 7.0, 5.4; IR (thin film): νmax 2955, 2913, 
2877, 1723, 1466, 1384, 1261, 1132, 1095; [α]D
20 +3.6 (7a, c 1.0, CHCl3); [α]D
20 -3.7 (ent-7a, c 0.32, CHCl3); 
HRMS (ESI+) calculated for C17H34O3SiI [M+H]+ 411.1316, found 411.1311. 
Proof of absolute configuration at C21 
Attempts at confirming the anticipated configuration5,6 of hydroxyester 7 from the diastereomeric 
MTPA esters was inconclusive, yielding inconsistent signs across both sides of the MTPA esters. The 
absolute configuration at C21 was unambiguously ascertained through the synthesis of the 
corresponding MTPA esters of ketone 7b. Experimental procedures for the synthesis of the 
diastereomeric MTPA esters are outlined below: 
Ketone – 7b 
 
A solution of ester 7a (42.5 mg, 0.182 mmol) in toluene (0.5 mL) was added via cannula to a stirred 
solution of methylmagnesium bromide (130 µL, 0.886 mmol, 3 M in Et2O) and triethylamine (255 µL, 
1.82 mmol) in toluene (2.5 mL). The mixture was heated to 80 °C and stirred until TLC monitoring 
indicated complete consumption of the starting material (ca. 4 h). The mixture was allowed to cool to 
r.t. and quenched with NH4Cl solution (2 mL). The layers were separated, and the aqueous phase 
extracted with Et2O (3 × 3 mL). The combined organic phases were dried (MgSO4) and the solvent 
removed under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 4%) 
afforded the product 7b as a pale-yellow oil (36.5 mg, 0.168 mmol, 92%). 
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Rf (EtOAc/PE 40-60: 30%) = 0.78; 1H NMR (400 MHz, CDCl3) dH 5.93 (1H, q, J = 1.0 Hz,  H18), 4.08 
(1H, t, J = 5.7 Hz, H21), 2.20 (2H, d, J = 5.7 Hz, H20), 2.15 (3H, s, H24), 1.84 (3H, d, J = 1.0 Hz, Me19), 
1.12 (3H, s, Me22a), 1.10 (3H, s, Me22b) 0.94 (9H, t, J = 8.0 Hz, Si(CH2CH3)3), 0.57 (6H, q, J = 8.0 Hz, 
Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) dC 213.3, 144.5, 78.4, 74.6, 52.9, 44.4, 27.0, 23.9, 22.2, 19.8, 
7.1, 5.4; IR (thin film): νmax 2945, 2910, 2876, 1702, 1459, 1353, 1238, 1088, 1004; [α]D
20 +16.4 (c 0.5, 
CHCl3); HRMS (ESI+) calculated for C16H32O2SiI [M+H]+ 411.1211, found 411.1206. 
Mosher esters – (R)-MTPA-7c and (S)-MTPA-7c 
 
A solution of TBAF (54 µL, 53.6 µmol, 1 M in THF) was added to a stirred solution of TES ether 7b (20 
mg, 48.7 µmol) in THF (0.5 mL). The pale-yellow solution was stirred for 1 h at r.t. before being 
quenched with a solution of NH4Cl (0.5 mL). The layers were separated and the aqueous phase was 
extracted with Et2O (3 × 1 mL). The combined organic phases were dried (MgSO4) and the solvent 
removed under reduced pressure to afford the crude hydroxyketone (11 mg, 38.5 µmol, 79%), which 
was used directly in subsequent steps without purification. 
(R)-Mosher ester – (R)-MTPA-7c 
DCC (54 µL, 54.0 µmol, 1 M in CH2Cl2) was added in portion to a stirred solution of crude 
hydroxyketone (4.0 mg, 13.5 µmol), (R)-MTPA (12 mg, 54.0 µmol) and DMAP (one crystal) in CH2Cl2 
(500 µL). The mixture was stirred for 24 h at r.t., during which the solution became a white suspension. 
The mixture was filtered through cotton wool and the filtrate reduced to dryness. Purification by flash 
chromatography (EtOAc/PE 40-60: 10%) afforded the product (R)-7c as a colourless oil (4.0 mg, 7.80 
µmol, 58%). 
Rf (EtOAc/PE 40-60: 20%) = 0.48; 1H NMR (400 MHz, CDCl3) dH 7.48-7.40 (5H, m, ArH), 5.94 (1H, s, 
H18), 5.66 (1H, dd, J = 9.8, 2.4 Hz, H21), 3.43 (3H, s, OMe), 2.43 (1H, dd, J = 14.3, 9.8 Hz, H20a), 2.31 
(1H, d br, J = 14.3 Hz, H20b), 2.13 (3H, s, H24), 1.93 (3H, s, Me19), 1.17 (3H, s, Me22a), 1.15 (3H, s, 
Me22b). 
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(S)-Mosher ester – (S)-MTPA-7c 
DCC (54 µL, 54.0 µmol, 1 M in CH2Cl2) was added in portion to a stirred solution of crude 
hydroxyketone (4.0 mg, 13.5 µmol), (S)-MTPA (12 mg, 54.0 µmol) and DMAP (one crystal) in CH2Cl2 
(500 µL). The mixture was stirred for 24 h at r.t., during which the solution became a white suspension. 
The mixture was filtered through cotton wool and the filtrate reduced to dryness. Purification by flash 
chromatography (EtOAc/PE 40-60: 10%) afforded the product (S)-7c as a colourless oil (4.6 mg, 8.97 
µmol, 66%). 
Rf (EtOAc/PE 40-60: 20%) = 0.48; 1H NMR (400 MHz, CDCl3) dH 7.49-7.41 (5H, m, ArH), 5.95 (1H, s, 
H18), 5.69 (1H, dd, J = 10.1, 2.3 Hz, H21), 3.49 (3H, s, OMe), 2.45 (1H, dd, J = 14.4, 10.1 Hz, H20a), 
2.30 (1H, br d, J = 14.4 Hz, H20b), 2.11 (3H, s, H24), 1.94 (3H, s, Me19), 1.13 (3H, s, Me22a), 1.12 (3H, 
s, Me22b). 
Following the advanced Mosher model described by Hoye et al.,7 the C21 centre arising from the 
enantioselective Mukaiyama aldol reaction was assigned as 21R. 
 
Table S1. Diagnostic 1H NMR signals for the configurational assignment of 21R 
Proton dH (S)-MTPA (ppm) dH (R)-MTPA (ppm) DdS-R (ppm) 
H24 2.11 2.13 –0.02 
Me22a 1.13 1.17 –0.04 
Me22b 1.12 1.15 –0.03 
H21 5.69 5.66 +0.03 
H20a 2.45 2.43 +0.02 
H20b 2.32 2.31 +0.01 
Me19 1.94 1.93 +0.01 
H18 5.95 5.94 +0.01 
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Alcohol 7d and ent-7d 
 
DIBAL (8.31 mL, 8.31 mmol, 1 M solution in hexanes) was added dropwise to a stirred solution of the 
ester 7a (1.80 g, 4.16 mmol) in CH2Cl2 (42 mL) at –78 °C. The reaction mixture was stirred at –78 °C for 
30 min before the addition of an extra aliquot of DIBAL (4.16 mL, 4.16 mmol, 1 M solution in hexanes). 
The reaction mixture was warmed to –40 °C over 1 h before quenching with the successive addition of 
MeOH (2 mL) and Na/K tartrate (30 mL). The mixture was allowed to warm to r.t. and stirred for 2 h. 
The layers were separated, and the aqueous phase extracted with CH2Cl2 (3 × 20 mL). The combined 
organic phases were washed with brine (20 mL), dried (MgSO4) and the solvent removed under reduced 
pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 10%  20%) afforded the 
product 7d as a colourless oil (1.31 g, 3.30 mmol, 79%, 90% brsm). 
The enantiomeric alcohol ent-7d was analogously prepared from ester ent-7a (1.00 g, 2.27 mmol) as a 
colourless oil (720 mg, 1.82 mmol, 73%). 
Rf (EtOAc/PE 40-60: 30%) = 0.80; 1H NMR (500 MHz, CDCl3) dH 5.98 (1H, s, H18), 3.72 (1H, dd, J = 
8.6, 2.6 Hz, H21), 3.67 (1H, dd, J = 10.7, 3.2 Hz, H23a), 3.28 (1H, dd, J = 10.7, 7.4 Hz, H23b), 2.66 (1H, 
dd, J = 7.4, 3.4 Hz, OH), 2.48 (1H, dd, J = 14.1, 2.6 Hz, H20a), 2.36 (1H, dd, J = 14.1, 8.6 Hz, H20b), 1.85 
(3H, d, J = 0.6 Hz, Me19), 1.04 (3H, s, Me22a), 0.96 (9H, t, J = 8.1 Hz, Si(CH2CH3)3), 0.80 (3H, s, Me22b), 
0.59, 0.58 (6H, app dq, J = 8.0 Hz, Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) dC 144.8, 78.2, 78.0, 70.0, 
43.7, 39.5, 24.0, 23.3, 21.5, 7.1, 5.4; IR (thin film): νmax 3477, 2955, 2927, 1459, 1318, 1274, 1090, 1006; 
[α]D
20  +17.8 (7d, c 0.15, CHCl3); [α]D
20  -14.7 (ent-7d, c 0.30, CHCl3); HRMS (ESI+) calculated for 
C15H31O2SiIH [M+H]+ 399.1216, found 399.1217. 
C18-C23 vinyl iodide 2 and ent-2 
 
TMSCl (342 µL, 2.70 mmol) was added to a stirred solution of alcohol 7d (855 mg, 2.16 mmol), Et3N 
(451 µL, 3.24 mmol) and DMAP (26.0 mg, 21.6 µmol) in CH2Cl2 (25 mL) at r.t.. The reaction was stirred 
at r.t. for 1 h before quenching with MeOH (1 mL). The solvent was removed under reduced pressure 
and the residue resuspended in PE 40-60 before filtering over a pad of silica, eluting with PE 40-60. 
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Removal of the solvent under reduced pressure afforded the C18-C23 vinyl iodide 2 as a colourless oil 
(924 mg, 1.96 mmol, 91%). 
The enantiomeric C18-C23 vinyl iodide ent-2 was analogously prepared from alcohol ent-7d (100 mg, 
252 µmol) to afford the product as a colourless oil (89 mg, 189 µmol, 75%). 
Rf (EtOAc/PE 40-60: 20%) = 0.66; 1H NMR (500 MHz, CDCl3) dH 5.88 (1H, s, H18), 3.77 (1H, dd, J = 
8.8, 2.4 Hz, H21), 3.34 (1H, d, J = 9.6 Hz, H23a), 3.22 (1H, d, J = 9.6 Hz, H23b), 2.37 (1H, dd, J = 13.6, 
2.4 Hz, H20a), 2.24 (1H, dd, J = 13.6, 8.8 Hz, H20b), 1.83 (3H, s, Me19), 0.94 (9H, t, J = 9.4 Hz, 
Si(CH2CH3)3), 0.82 (3H, s, Me22a), 0.79 (3H, s, Me22b), 0.55 (6H, q, J = 9.4 Hz, Si(CH2CH3)3), 0.08 (9H, 
s, Si(CH3)3); 13C NMR (125 MHz, CDCl3) dC 145.8, 74.0, 69.2, 43.4, 40.3, 24.0, 21.1, 20.2, 7.2, 5.5, –0.6; 
IR (thin film): νmax 2877, 2597, 1251, 1092, 1013, 874; [α]D
20 +9.6 (2, c 0.28, CHCl3);	[α]D20 -9.0 (ent-2, c 
0.32, CHCl3); HRMS (ESI+) calculated for C18H39O2Si2IH [M+H]+ 471.1612, found 471.1615. 
 
 
2.3. Synthesis of the C10-C17 aldehyde 
Vinyl iodide 8a 
 
AlMe3 (89 mL, 178 mmol, 2.0 M solution in hexane) was added dropwise to a stirred solution of 
Cp2ZrCl2 (5.20 g, 17.8 mmol) in dichloroethane (200 mL) at –30 °C. The solution was stirred at –30 °C 
for 5 min before the dropwise addition of H2O (535 µL, 29.7 mmol) into the reaction mixture. The 
resultant mixture was allowed to warm to r.t. over 10 min before cooling to –30 °C. A solution of 4-
pentyn-1-ol (5.53 ml, 59.4 mmol) in dichloroethane (97 mL) was added dropwise via cannula to the 
reaction mixture at –30 °C. The reaction mixture was allowed to warm to r.t. and stirred at r.t. for 20 h 
before cooling to– 30°C. A solution of I2 (30.1 g, 119 mmol) in THF (59 mL) was added dropwise via 
cannula to the reaction mixture. The resulting mixture was stirred at – 30°C for a further 2 h before 
quenching with Na/K tartrate (200 mL), warming to r.t. and stirred for 16 h at r.t.. The resulting 
suspension was filtered to remove excess salts and the layers were separated. The aqueous layer was 
extracted with CH2Cl2 (3 ´  100mL) and the combined organic phases were washed with brine (300 mL), 
dried (MgSO4), and the solvent removed under reduced pressure. Purification by flash column 
14
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chromatography (EtOAc/PE 40-60: 30%  50%) gave the vinyl iodide 8a as an orange oil (11.7 g, 51.7 
mmol, 87%). 
Rf (EtOAc/PE 40-60: 50%) = 0.40; 1H NMR (400 MHz, CDCl3) dH 5.94 (1H, q, J = 1.2 Hz, H10), 3.65 
(2H, t, J = 6.4 Hz, H14), 2.32 (2H, td, J = 7.5, 1.1 Hz, H12), 1.87 (3H, d, J = 1.2 Hz, Me11), 1.76-1.68 (2H, 
m, H13). 
Data in agreement as presented by Clausen et al.8  
Chlorohydrin 10 
 
Dess-Martin Periodinane (28.8 g, 68.1 mmol) was added to a stirred suspension of alcohol 8a (12.8 g, 
56.7 mmol), NaHCO3 (14.3 g, 170 mmol) in CH2Cl2 (189 mL). The reaction mixture was stirred at r.t. 
for 1 h before quenching with the addition of NaHCO3 (70 mL), Na2S2O3 (70 mL) and H2O (70 mL). 
The mixture was stirred for 2 h before the layers were separated. The aqueous layer was extracted with 
CH2Cl2 (3 ´ 100 mL). The combined organic phases were washed with brine (300 mL), dried (MgSO4), 
and the solvent removed under reduced pressure to afford the crude aldehyde 9 (12.1 g, 53.9 mmol, 
95%), which was used directly in subsequent steps without purification. 
NCS (4.31 g, 32.3 mmol) was added to a stirred solution of aldehyde 9 (8.04 g, 35.9 mmol), L-proline 
(3.72 g, 32.3 mmol) in CH2Cl2 (120 mL). The reaction was stirred at r.t. until complete chlorination of 
the aldehyde was observed by NMR (ca. 2 h). At this point, 2,2-dimethyl-1,3-dioxan-5-one (5.62 g, 43.1 
mmol) was added and the reaction mixture was stirred at r.t. for 24 h. The reaction was quenched by 
addition of brine (100 mL) and the layers separated. The organic phase was washed with brine (100 mL) 
and the combined aqueous phases were extracted with CH2Cl2 (3 ´ 150 mL). The combined organic 
phases were dried (MgSO4), and the solvent removed under reduced pressure. Purification by flash 
column chromatography (EtOAc/PE 40-60: 10%  25%) afforded chlorohydrin 10 as a yellow oil (6.57 
g, 16.9 mmol, 47%, 98% ee) as a separable 5.3 : 1 mixture of diastereomers. 
Rf (EtOAc/PE 40-60: 20%) = 0.35; 1H NMR (600 MHz, CDCl3) dH 6.15 (1H, q, J = 1.2 Hz, H10), 4.39 
(1H, dd, J = 8.9, 1.5 Hz, H15), 4.33–4.26 (2H, m, H13, H17a), 4.08 (1H, d, J = 17.6 Hz, H17b), 3.88 (1H, 
ddd, J = 8.9, 3.0, 1.7 Hz, H14), 3.39 (1H, dd, J = 3.0, 1.4 Hz, OH), 2.80 (2H, dt, J = 7.7, 1.3 Hz, H12), 1.88 
(3H, d, J = 1.1 Hz, Me11), 1.51 (3H, s, MeAMeBCO2), 1.43 (s, 3H, MeAMeBCO2); 13C NMR (150 MHz, 
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CDCl3) δc 212.4, 143.2, 101.8, 79.5, 72.8, 70.6, 66.5, 58.6, 43.8, 24.0, 23.9, 23.5; IR : νmax 3513, 2987, 1738, 
1376, 1222, 1086, 863; [α]D
20 –68.2 (c 1.54, CHCl3); Chiral HPLC (Chiralpak® IG, iPrOH : n-hexane: 1%) 
RT (major) 3.47 min, RT (minor) 2.98 min; HRMS (ESI+) calculated for C12H18ClIO4Na [M+Na]+ 
410.9830, found 410.9841.  
Alcohol 11 
 
MeMgI (27.6 mL, 82.8 mmol, 3.0 M solution in Et2O) was added dropwise to a stirred solution of 
chlorohydrin 9 (9.17 g, 23.6 mmol) in CH2Cl2 (79 mL) at –78 °C. The reaction was stirred at –78 °C for 
24 h before quenching with HCl (100 mL, 1.0 M solution in H2O) and warmed to r.t.. The layers were 
separated, and the aqueous phase was extracted with CH2Cl2 (3 ´ 100 mL). The combined organic 
phases were washed with brine (300 mL), dried (MgSO4), and the solvent removed under reduced 
pressure to afford the crude alcohol as a 6:1 mixture of diastereomers at C16. Purification by flash 
column chromatography (EtOAc/PE 40-60: 20%  30%) afforded alcohol 11 as an off-white solid (4.69 
g, 11.6 mmol, 49%) as a single diastereomer. 
Rf (EtOAc/PE 40-60: 30%) = 0.39; 1H NMR (600 MHz, CDCl3) dH 6.14 (1H, q, J = 1.2 Hz, H10), 4.41 
(1H, ddd, J = 9.0, 6.1, 1.4 Hz, H13), 3.79 (1H, d, J = 9.2 Hz, H15), 3.74-3.69 (2H, m, H14, H17a), 3.49 
(1H, d, J = 11.3 Hz, H17b), 2.76 (1H, ddd, J = 14.3, 9.0, 1.0 Hz, H12a), 2.74 (1H, s, OH16), 2.70 (1H, 
ddd, J = 14.3, 6.1, 1.2 Hz, H12b), 2.47 (1H, d, J = 8.6 Hz, OH14), 1.89 (3H, d, J = 1.1 Hz, Me11), 1.47 
(3H, s, MeAMeBCO2), 1.41 (3H, s, Me16), 1.38 (s, 3H, MeAMeBCO2).; 13C NMR (150 MHz, CDCl3) δc 
143.2, 99.7, 79.3, 73.6, 72.9, 70.3, 68.2, 60.8, 44.3, 28.9, 23.8, 20.5, 19.2.; IR νmax 3397, 3320, 2998, 2876, 
1377, 1146, 1080, 1043, 860, 519; [α]D
20 –8.7 (c 1.3, CHCl3); HRMS (ESI+) calculated for C13H22ClIO4Na 
[M+Na]+ 427.0149, found 427.0155. 
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Proof of absolute configuration at C14 
The absolute configuration at C14 arising from the L-proline-catalysed aldol reaction was determined 
by synthesising the diastereomeric Mosher esters (R)- and (S)-MTPA-11 from alcohol 11. 
Mosher esters – (R)-MTPA-11 and (S)-MTPA-11 
 
(R)-Mosher ester – (R)-MTPA-11 
A stock solution of DMAP (1.2 mg) in CH2Cl2 (1 mL) was separately prepared, of which an aliquot of 
the DMAP stock solution (250 µL) was used to dissolve alcohol 11 (10.0 mg, 24.7 µmol). DIC (5.7 µL, 
37 µmol) and (R)-MTPA (8.7 mg, 37 µmol) was added to this solution and the resulting mixture was 
stirred at r.t. for 24 h, after which product formation was observed by TLC. The solution was diluted 
with CH2Cl2 (1 mL) and quenched with NaHCO3 (1 mL) was added. The layers were separated, and the 
aqueous phase was extracted with CH2Cl2 (2 ´ 2 mL) The organic layers were combined, washed with 
brine (5 mL), dried (Na2SO4), and concentrated. Purification by flash column chromatography 
(EtOAc/PE 40-60: 10%  20%) afforded the product (R)-MTPA-11 as a colourless oil (3.4 mg, 5.4 
µmol, 23%). 
Rf (EtOAc/PE 40-60: 30%) = 0.48; 1H NMR (600 MHz, CDCl3) δH 7.65 (2H, dd, J = 7.1, 2.8 Hz, ArH), 
7.47–7.42 (3H, m, ArH), 6.03 (1H, q, J = 1.1 Hz, H10), 5.19 (1H, dd, J = 9.1, 1.4 Hz, H14), 4.43 (1H, ddd, 
J = 10.4, 4.3, 1.3 Hz, H13), 4.11 (1H, d, J = 9.1 Hz, H15), 3.65 (3H, s, OMe), 3.60 (1H, d, J = 11.8 Hz, 
H17a), 3.34 (1H, d, J = 11.4 Hz, H17b), 2.60 (1H, m, H12a), 2.40 (1H, ddd, J = 14.6, 10.4, 0.8 Hz, H12b), 
1.86 (3H, d, J = 1.0 Hz, Me11), 1.46 (3H, s, MeAMeBCO2), 1.38 (3H, s, MeAMeBCO2), 1.14 (3H, s, Me16). 
(S)-Mosher ester – (S)-MTPA-11 
A stock solution of DMAP (1.2 mg) in CH2Cl2 (1 mL) was separately prepared, of which an aliquot of 
the DMAP stock solution (400 µL) was used to dissolve alcohol 11 (16.0 mg, 39.5 µmol). DIC (122 µL, 
0.79 mmol) and (S)-MTPA (92.5 mg, 0.40 mmol) was added to this solution and the resulting mixture 
was stirred at r.t. for 5 h, after which product formation was observed by TLC. The mixture was diluted 
with CH2Cl2 (1 mL) and quenched with NaHCO3 (1 mL) was added. The layers were separated, and the 
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aqueous phase was extracted with CH2Cl2 (2 x 2 mL) The organic layers were combined, washed with 
brine (5 mL), dried (Na2SO4), and concentrated. Purification by flash column chromatography 
(EtOAc/PE 40-60: 10%) afforded the product (S)-MTPA-11 as a colourless oil (10.5 mg, 17.0 µmol, 
43%). 
Rf (EtOAc/PE 40-60: 30%) = 0.70; 1H NMR (500 MHz, CDCl3) δH 7.69-7.64 (2H, m, ArH), 7.46-7.40 
(3H, m, ArH), 5.82 (1H, q, J = 1.1 Hz, H10), 5.16 (1H, dd, J = 9.2, 1.4 Hz, H14), 4.37 (1H, ddd, J = 10.8, 
3.9, 1.4 Hz, H13), 4.20 (1H, d, J = 9.1 Hz, H15), 3.70 (1H, d, J = 11.5 Hz, H17a), 3.47 (3H, s, OMe), 3.45 
(1H, d, J = 11.5 Hz, H17b), 2.48 (1H, ddd, J = 14.7, 4.0, 1.3 Hz, H12a), 2.11 (1H, dd, J = 14.5, 10.8 Hz, 
H12b), 1.80 (3H, d, J = 1.1 Hz, Me11), 1.48 (3H, s, MeAMeBCO2), 1.40 (3H, s, MeAMeBCO2), 1.29 (3H, s, 
Me16). 
Following the advanced Mosher model described by Hoye et al.,7 the C14 centre arising from the 
enantioselective L-proline catalysed aldol reaction was assigned as 14R. 
Table S2. Diagnostic 1H NMR signals for the configurational assignment of 14R 
Proton dH (S)-MTPA-11 (ppm) dH (R)-MTPA-11 (ppm) DdS-R (ppm) 
Me11 1.80 1.86 -0.06 
H12b 2.11 2.40 -0.29 
H12a 2.48 2.60 -0.12 
H13 4.37 4.43 -0.06 
H14 5.16 5.19 -0.03 
H15 4.20 4.11 +0.09 
Me16 1.29 1.14 +0.15 
H17a 3.70 3.60 +0.10 
H17b 3.45 3.34 +0.11 
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Triol 12 
 
Alcohol 11 (1.50 g, 4.57 mmol) was dissolved in MeOH (50 mL) in a pressurised vessel and heated to 
120 °C over 15 minutes in a microwave, reaching a pressure of 250 psi. The reaction was maintained at 
120 °C at 250 psi for 110 minutes before cooling to r.t.. The solvent was removed under reduced pressure 
and the product was purified by flash column chromatography (EtOAc: 100%) to afford triol 12 as an 
off-white solid (1.21 g, 3.66 mmol, 67%). 
Rf (CH2Cl2/MeOH: 10%) = 0.42; 1H NMR (600 MHz, CDCl3) δH 6.05 (1H, q, J = 1.2 Hz, H10), 4.09 (1H, 
d, J = 6.3 Hz, H15), 3.96 (1H, ddd, J = 7.5, 6.1, 5.3 Hz, H13), 3.83 (1H, t, J = 6.2 Hz, H14), 3.49 (1H, d, J 
= 11.6 Hz, H17a), 3.44 (1H, d, J = 11.6 Hz, H17b), 2.52 (1H, ddd, J = 14.5, 5.3, 1.2 Hz, H12a), 2.44 (1H, 
ddd, J = 14.5, 7.5, 1.2 Hz, H12b), 1.90 (3H, d, J = 1.1 Hz, Me11), 1.19 (3H, s, Me16). 13C NMR (150 MHz, 
CDCl3) δc 144.7, 84.8, 79.6, 77.3, 75.4, 72.2, 67.8, 43.3, 24.8, 17.3; IR νmax 3301, 2924, 1105, 1045, 1023, 
761, 676, 574, 558; [α]D
20  -22.1 (c 1.63, MeOH); HRMS (ESI+) calculated for C10H17IO4Na [M+Na]+ 
351.0063, found 351.0078. 
The relative configuration in triol 12 was confirmed by observing a NOE enhancement between H13 
and Me16, placing H13 and Me16 in a syn configuration. Additionally, no NOE enhancements were 
observed between H13 and H14, as well as H15 and Me16. This support that H13, OH14, OH15 and 
Me16 are in a syn relationship around the THF ring (Figure S1). This result is also supported by NOE 
data obtained for alcohol 14 (vide infra).  
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Figure S1. Observed NOE correlations confirming the relative configuration of triol 12 
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Alcohol 12a 
 
1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane (5.07 mL, 15.8 mmol) was added dropwise to a stirred 
solution of triol 12 (4.33 g, 13.2 mmol) in CH2Cl2 (33 mL) and pyridine (11 mL) at 0 °C. The solution 
was allowed to warm to r.t. and stirred for 48 h at r.t. before quenching with NH4Cl (50 mL). The layers 
were separated and the organic phase was washed with NH4Cl (50 mL). The combined aqueous phase 
was extracted with CH2Cl2 (2 ´ 50 mL) and the combined organic phases were washed with brine (100 
mL), dried (MgSO4) and concentrated under reduced pressure. Purification by flash column 
chromatography (EtOAc/PE 40-60: 5%  10%) afforded alcohol 12a as a yellow oil (6.68 g, 11.7 mmol, 
89%). 
Rf (EtOAc/PE 40-60: 20%) = 0.72; 1H NMR (600 MHz, CDCl3) dH 6.02 (1H, q, J = 1.2 Hz, H10), 4.13-
4.07 (2H, m, H13, H15), 3.80 (1H, dd, J = 6.9, 2.9 Hz, H14), 3.66 (2H, d, J = 2.3 Hz, H17), 2.86 (1H, s, 
OH), 2.47-2.39 (2H, m, H12), 1.90 (3H, d, J = 1.1 Hz, Me11), 1.24 (3H, s, Me16), 1.12-0.97 (24H, m, 
iPrSi).; 13C NMR (150 MHz, CDCl3) δc 144.5, 83.1, 81.1, 77.4, 75.0, 74.8, 69.8, 44.0, 25.0, 17.6, 17.7, 17.6, 
17.5, 17.4, 17.3, 17.3, 17.2, 17.1, 13.5, 13.0, 13.0, 12.8; IR νmax 2944, 2867, 1464, 1113, 1035, 885, 867, 692; 
[α]D
20  –10.6 (c 0.82, CHCl3); HRMS (ESI+) calculated for C22H43IO5Si2H [M+H]+ 571.1766, found 
571.1776. 
Siloxane 13 
  
Pyridine (5.28 mL, 65.3 mmol) was added to a solution of alcohol 12a (7.45 g, 13.1 mmol) in CH2Cl2 
(43 mL) and the solution was cooled to 0 °C, to which Tf2O (5.49 mL, 32.7 mmol) was added dropwise 
to the stirred solution at 0 °C. Upon completion, the stirred solution was allowed to warm to r.t. over 1 
h before quenching with NaHCO3 (50 mL). The layers were separated, and the aqueous layer was 
extracted with CH2Cl2 (3 ´ 50 mL). The organic layers were combined, washed with brine (150 mL), 
dried (MgSO4), and the solvent removed under reduced pressure. The crude product was filtered over 
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a plug of silica, eluting with CH2Cl2 (90 mL). Owing to the instability of the product, triflate 12b was 
used immediately in the subsequent step without further purification. 
nBu4BH4 (10.1 g, 39.2 mmol) was added to a stirred solution of the crude triflate 12b (3.21 g, ca. 44.5 
mmol) in PhMe (43 mL) at r.t.. The mixture was heated to 50 °C and stirred for 1 h before the addition 
of NH4Cl (50 mL) and allowing the mixture to cool to r.t.. The layers were separated, and the aqueous 
phase extracted with EtOAc (3 ´ 50 mL). The combined organic phases were washed with brine (150 
mL), dried (MgSO4), and the solvent removed under reduced pressure. Purification by flash column 
chromatography (EtOAc/PE 40-60: 2%  5%) afforded siloxane 13 as a clear oil (5.07 g, 9.14 mmol, 
68% over two steps). 
Rf (EtOAc/PE 40-60: 10%) = 0.53; 1H NMR (600 MHz, CDCl3) dH 5.94 (1H, q, J = 1.1 Hz, H10), 4.29 
(1H, t, J = 8.8 Hz, H15), 4.19 (1H, dddd, J = 9.2, 6.9, 5.9, 3.6 Hz, H13), 3.69 (1H, d, J = 11.7 Hz, H17a), 
3.64 (1H, d, J = 11.7 Hz, H17b), 2.43 (1H, ddd, J = 14.0, 5.9, 1.2 Hz, H12a), 2.28 (1H, ddd, J = 14.0, 7.0, 
1.0 Hz, H12b), 2.13-2.04 (1H, m, H14a), 1.94-1.84 (1H, m, H14b), 1.86 (3H, d, J = 1.1 Hz, Me11), 1.11 
(3Hm s, 3H, Me16), 1.13-1.01 (28H, m, iPrSi).; 13C NMR (150 MHz, CDCl3) δc 145.0, 83.1, 77.1, 73.0, 
72.0, 68.4, 46.8, 37.3, 24.9, 17.7, 17.6, 17.6, 17.6, 17.6, 17.5, 17.4, 17.3, 17.3, 17.2, 16.4, 13.6, 13.2, 12.8, 
12.8; IR νmax 2943, 2867, 1464, 1105, 1032, 885, 692; [α]D
20 –7.2 (c 0.93, CHCl3); HRMS (ESI+) calculated 
for C22H43IO4Si2H [M+H]+ 555.1817, found 555.1803. 
Diol 13a 
 
Siloxane 13 (1.16 g, 2.09 mmol) was dissolved in a solution of HCl in MeOH (21 mL, 21.0 mmol, 0.1 M) 
and stirred at 50 °C for 7 h. The reaction was quenched by the addition of solid NaHCO3 (ca. 3 g) and 
the mixture diluted with CH2Cl2 (60 mL). The solids were filtered off, the filtrate collected, and the 
solvents removed under reduced pressure. Purification by flash column chromatography (EtOAc/PE 
40-60: 80%) afforded diol 13a as clear oil (546 mg, 1.75 mmol, 84%). 
Rf (EtOAc)= 0.52; 1H NMR (600 MHz, CDCl3) dH 5.99 (1H, q, J = 1.0 Hz, H10), 4.31 (1H, qn, J = 6.8 Hz, 
H13), 4.25 (1Hm, dd, J = 6.8, 4.6 Hz, H15), 3.45 (1H, d, J = 11.2 Hz, H17a), 3.41 (1H, d, J = 11.3 Hz, 
H17b), 2.46 (1H, dd, J = 14.1, 6.8 Hz, H12a), 2.32 (1H, dd, J = 14.1, 6.2 Hz, H12b), 2.09-1.96 (3H, m, 
H14a, OH, OH), 1.89 (1H, dd, J = 13.7, 6.5 Hz, H14b), 1.86 (3H, d, J = 1.0 Hz, Me11), 1.16 (3H, s, Me16).; 
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13C NMR (150 MHz, CDCl3) dC 144.9, 85.5, 77.2, 74.1, 73.4, 67.8, 46.1, 40.2, 24.6, 17.1.; IR νmax 3377, 
2933, 1376, 1274, 1044, 769, 669; [α]D
20 +6.5 (c 1.0, MeOH); HRMS (ESI+) calculated for C10H17IO3NH4 
[M+NH4]+ 330.0566, found 330.0526. 
TBS ether 14 
 
Diol 13a (707 mg, 2.26 mmol) and imidazole (462 mg, 6.78 mmol) were dissolved in CH2Cl2 (23 mL) 
and cooled to 0 °C. TBSCl (406 mg, 2.71 mmol) was added and the solution was allowed to warm to r.t. 
over 2 h before quenching with NH4Cl (20 mL). The layers were separated, and the aqueous layer was 
extracted with CH2Cl2 (3 ´ 20 mL). The organic layers were combined, washed with brine (60 mL), 
dried (MgSO4), and the solvent removed under reduced pressure. Purification by flash column 
chromatography (EtOAc/PE 40-60: 10%  30%) afforded TBS ether 14 as a clear oil (802 mg, 1.88 
mmol, 83%). 
Rf (EtOAc/PE 40-60: 20%) = 0.53; 1H NMR (500 MHz, CDCl3) dH 5.96 (1H, q, J = 1.0 Hz, H10), 4.29 
(1H, ddd, J = 13.0, 7.3, 6.6 Hz, H13), 4.24 (1H, dt, J = 6.4, 4.0 Hz, H15), 3.47 (1H, d, J = 9.8 Hz, H17a), 
3.36 (1H, d, J = 9.8 Hz, H17b), 2.48 (1H, dd, J = 13.9, 6.4 Hz, H12a), 2.31 (1H, dd, J = 13.9, 6.7 Hz, H12b), 
1.95* (1H, ddd, J = 13.0, 6.5, 4.2 Hz, H14a), 1.92-1.87* (1H, m, H14b), 1.86 (3H, d, J = 1.0 Hz, Me11), 
1.65 (1H, d, J = 4.3 Hz, OH), 1.19 (3H, s, Me16), 0.89 (9H, s, SiMe2tBu), 0.06 (6H, s, SiMe2tBu); 13C 
NMR (125 MHz, CDCl3) dC 144.9, 83.4, 79.3, 74.1, 67.9, 46.0, 41.0, 25.7, 24.3, 22.5, 18.0, –5.5, –5.8; IR 
(thin film): νmax 3439, 2928, 2857, 1463, 1258, 1088 779; [α]D
20  –1.7 (c 0.24, CHCl3); HRMS (ESI+) 
calculated for C16H31O3SiIH [M+H]+ 427.1165, found 427.1162. 
*H14 signals that are particularly characteristic against a 15S assignment in phormidolide A (H14: 2.33 
and 1.57 ppm for H14a and H14b respectively in phormidolide A vs. 1.95 and 1.90 ppm for H14a and 
H14b in 14). For comparison, H14a and H14b appears at 2.36 and 1.69 ppm in alcohol 15 possessing 
the 15R configuration, which is the configuration reported in phormidolide A (vide infra). NOE analysis 
of alcohol 14, compared with the reported NOE enhancements observed in phormidolide A also 
supports our conclusion. 
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NOE analysis of TBS ether 14 
1. Correlations were observed in the 1H-1H NOESY spectrum between H15 and H12/H17, 
showing that H15 lies on the same side as the two alkyl substituents. This correlation is not seen 
in alcohol 15 where the C15 configuration is inverted (vide infra). 
2. Correlation was observed between H13 and Me16, positioning the two substituents syn to each 
other 
3. No correlations were observed between H15 and Me16, suggesting that H15 and Me16 lie anti 
to each other 
These observations suggest that H15 lie anti to both H13 and Me16, placing H15 in an S configuration 
(Figure S2). In phormidolide A, NOE enhancements were observed for H15 to H14b and Me16, with 
H14b correlating to H13. H14a reported no NOE enhancements to any THF signals. These differential 
results, alongside with chemical shift analysis, confirm that phormidolide does not contain the S 
configuration at C15. 
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Figure S2. Diagram highlighting the NOE correlations observed for alcohol 14. The reported NOE enhancements for 
phormidolide A is presented alongside for comparison  
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Ketone 14a 
 
Dess-Martin Periodinane (311 mg, 733 µmol) was added to a stirred suspension of alcohol 14 (125 mg, 
293 µmol) and NaHCO3 (100 mg, 1.17 mmol) in wet CH2Cl2 (4 mL). The reaction mixture was stirred 
at r.t. until TLC monitoring indicated full consumption of the starting material (ca. 30 min). The 
reaction mixture was quenched by the addition of NaHCO3 (2 mL) and Na2S2O3 solution (2 mL) and 
stirred at r.t. for 30 min. The layers were separated, and the aqueous phase was extracted with CH2Cl2 
(3 × 2 mL). The combined organic phases were dried (MgSO4) and concentrated under reduced 
pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 0%  5%) afforded the 
product 14a as a colourless oil (123 mg, 290 µmol, 99%). 
Rf (EtOAc/PE 40-60: 20%) = 0.71; 1H NMR (500 MHz, CDCl3) dH 6.03 (1H, q, J = 0.9 Hz, H10), 4.33 
(1H, app dq, J = 10.5, 6.1 Hz, H13), 3.64 (1H, d, J = 10.5 Hz, H17a), 3.53 (1H, d, J = 10.5 Hz, H17b), 2.71 
(1H, dd, J = 14.3, 6.1 Hz, H14a), 2.55 (1H, dd, J = 14.3, 6.1 Hz, H14b), 2.48 (1H, dd, J = 17.4, 5.8 Hz, 
H12a), 2.19 (1H, dd, J = 17.4, 10.5 Hz, H12b), 1.92, (3H, d, J = 0.9 Hz, Me11), 1.09 (3H, s, Me16), 0.87 
(9H, s, SiMe2tBu), 0.05 (3H, s, SiMe2tBu), 0.02 (3H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 216.2, 
144.1, 84.8, 77.5, 71.6, 67.3, 45.6, 43.3, 25.9, 24.6, 18.3, 17.7, –5.3, –5.6; IR (thin film): νmax 2948, 2867, 
1762, 1454, 1253, 1098, 898; [α]D
20  +16.3 (c 0.95, CHCl3); HRMS (ESI+) calculated for C16H29O3SiIH 
[M+H]+ 425.1009, found 425.1006. 
Alcohol 15 XX-755-NOE 
 
DIBAL (1.69 mL, 1.69 mmol, 1 M solution in hexanes) was added dropwise to a stirred solution of 
ketone 14a (239 mg, 563 µmol) in CH2Cl2 (6 mL) at –78 °C. The reaction mixture was stirred at –78 °C 
for 1 h before quenching with MeOH (500 µL), Na/K tartrate (5 mL) and the stirred mixture allowed to 
warm to r.t. over 3 h. The layers were separated, and the aqueous phase was extracted with CH2Cl2 (3 × 
5 mL). The combined organic phases were dried (MgSO4) and concentrated under reduced pressure. 
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Purification by flash column chromatography (EtOAc/PE 40-60: 2%) afforded the product 15 as a 
colourless oil (238 mg, 559 µmol, 99%) as a single diastereomer. 
Rf (EtOAc/PE 40-60: 20%) = 0.53; 1H NMR (500 MHz, CDCl3) dH 5.99 (1H, s, H10), 4.14-4.11 (2H, m, 
H13, H15), 3.76 (1H, d, J = 10.3 Hz, H17a), 3.67 (1H, d, J = 10.3 Hz, H17b), 3.55 (1H, d, J = 6.2 Hz, 
OH15), 2.59 (1H, dd, J = 13.9, 6.8 Hz, H12a), 2.43 (1H, dd, J = 13.9, 6.3 Hz, H12b), 2.39-2.32* (1H, m, 
H14a), 1.88 (3H, s, Me11), 1.70-1.64* (1H, m, H14b), 1.15 (3H, s, Me16), 0.93 (9H, s, SiMe2tBu), 0.13 
(3H, s, SiMe2tBu), 0.12 (3H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 144.9, 83.4, 79.3, 74.1, 67.9, 
46.0, 41.0, 25.7, 24.3, 22.5, 18.0, –5.5, –5.8; IR (thin film): νmax 3439, 2928, 2857, 1463, 1258, 1088 779; 
[α]D
20 –1.7 (c 0.24, CHCl3); HRMS (ESI+) calculated for C16H31O3SiIH [M+H]+ 427.1165, found 427.1162. 
*H14 signals that are particularly characteristic in support of the reported 15R assignment present in 
phormidolide A (2.33 and 1.57 ppm for H14a and H14b respectively in phormidolide A vs. 2.36 and 
1.69 ppm for H14a and H14b in 15). For comparison, H14a and H14b appears at 1.95 and 1.90 ppm in 
alcohol 14 possessing the 15S configuration (vide supra). All subsequent intermediates bearing the 
reported 15R configuration contain a signal at ca. 2.30- 2.40 ppm, and another at 1.60-1.70 ppm for the 
diastereotopic protons of H14, which favourably compares with the ones reported for phormidolide A 
but not with structures bearing the 14S configuration. 
NOE analysis for alcohol 15 
1) Correlations were observed between H15 to H14a and Me16, suggesting the three groups are 
positioned syn to each other 
2) Correlations were observed between H13 and Me16, suggesting that H13 and Me16 are 
positioned syn to each other. This also means that H15, H14a and H13 are positioned syn to 
each other 
3) No correlations were observed for either H13/H15 or Me16 to H14b, 
This suggests that the H13 and H15 lies syn to H14a and Me16, giving the 15R configuration (Figure 
S3). Notably, the observed correlations are in contrast to the ones observed for alcohol 14 (vide supra). 
The chemical shift values, alongside with NOE enhancements match very favourably to the ones 
reported in phormidolide A, giving strong evidence that the relative configuration in the THF, 
especially at C15, is configured correctly as the 15R configuration. 
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Figure S3. NOE correlations observed for alcohol 15 (spectrum acquired in d3-MeCN to separate the superimposed H13 and 
H15) in support of the 15R configuration 
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Ester 16 
 
DCC (2.27 mL, 2.27 mmol, 1 M solution in CH2Cl2) was added in one portion to a stirred solution of 
alcohol 15 (160 mg, 378 µmol), dimethylacrylic acid (227 mg, 2.27 mmol), DMAP (277 mg, 2.27 mmol) 
and DMAP·HCl (359 mg, 2.27 mmol) in CH2Cl2 (4 mL) at r.t.. The cloudy white suspension was stirred 
at r.t. for 24 h before quenching with NH4Cl (5 mL). The layers were separated, and the aqueous phase 
was extracted with Et2O (3 × 5 mL). The combined organic phases were dried (MgSO4) and 
concentrated under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 
0%  5%) afforded the product 16 as a colourless oil (178 mg, 350 µmol, 93%). 
Rf (EtOAc/PE 40-60: 20%) = 0.72; 1H NMR (500 MHz, CDCl3) dH 5.94 (1H, d, J = 1.0 Hz, H10), 5.66 
(1H, sept, J = 1.2 Hz, =CH), 5.10 (1H, dd, J = 6.4, 3.9 Hz, H15), 4.22 (1H, ddt, J = 7.5, 6.8, 6.5 Hz, H13), 
3.70 (1H, d, J = 9.7 Hz, H17a), 3.50 (1H, d, J = 9.7 Hz, H17b), 2.56 (1H, dd, J = 13.9, 6.8 Hz, H12a), 2.46 
(1H, ddd, J = 13.8, 7.5, 6.6 Hz, H14a), 2.38 (1H, dd, J = 13.9, 6.6 Hz, H12b), 2.17 (3H, d, J = 1.7 Hz, 
=CMeaMeb), 1.91 (3H, d, J = 1.2 Hz, =CMeaMeb), 1.85 (3H, d, J = 1.0 Hz, Me11), 1.70 (1H, ddd, J = 13.9, 
6.4, 3.9 Hz, H14b), 1.20 (3H, s, Me16), 0.86 (9H, s, SiMe2tBu), 0.03 (3H, s, SiMe2tBu), 0.01 (3H, s, 
SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 165.7, 157.4, 144.9, 116.0, 84.5, 77.2, 74.5, 66.0, 46.3, 37.6, 
27.4, 25.8, 24.5, 21.7, 20.3, 18.2, –5.5, –5.6; IR (thin film): νmax 2927, 2853, 1723, 1561, 1444, 1144,1103; 
[α]D
20  –13.0 (c 0.30, CHCl3); HRMS (ESI+) calculated for C21H37O4SiIH [M+H]+ 509.1579, found 
509.1572. 
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Alcohol 16a 
 
TsOH·H2O (3.5 mg, 20.3 µmol) was added to a stirred solution of TBS ether 16 (103 mg, 203 µmol) in 
MeOH (1 mL) and CH2Cl2 (1 mL) at r.t.. The reaction mixture was stirred for 3 h at r.t., after which it 
was diluted with CH2Cl2 (5 mL) and quenched by the addition of NaHCO3 (10 mL). The layers were 
separated, and the aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The combined organic phases 
were dried (MgSO4) and concentrated under reduced pressure. Purification by flash column 
chromatography (EtOAc/PE 40-60: 20%) afforded the product 16a as a colourless oil (54.6 mg, 138 
µmol, 68%). 
Rf (EtOAc/PE 40-60: 20%) = 0.23; 1H NMR (400 MHz, CDCl3) dH 5.99 (1H, s, H10), 5.70 (1H, s, =CH), 
5.08 (1H, dd, J = 6.8, 4.9 Hz, H15), 4.22 (1H, app qn, J = 6.8 Hz, H13), 3.57 (1H, dd, J = 11.8, 6.3 Hz, 
H17a), 3.51 (1H, dd, J = 11.8, 6.2 Hz, H17b), 2.57 (1H, dd, J = 13.9, 6.4 Hz, H12a), 2.52 (1H, ddd, J = 
13.6, 6.8, 6.8 Hz, H14a), 2.42 (1H, dd, J = 13.9, 6.3 Hz, H12b), 2.18 (3H, s, =CMeaMeb), 1.93 (3H, s, 
=CMeaMeb), 1.87 (3H, s, Me11), 1.72 (1H, ddd, J = 13.5, 7.1, 4.9 Hz, H14b), 1.26 (3H, s, Me16); 13C 
NMR (100 MHz, CDCl3) dC 166.4, 159.1 144.6, 115.3, 84.1, 78.1, 77.2, 74.1, 65.8, 46.0, 37.7, 27.6, 24.5, 
21.7, 20.4; IR (thin film): νmax 3511, 2919, 1717, 1649, 1377, 1228, 1145, 1008; [α]D
20 +2.2 (c 0.19, CHCl3); 
HRMS (ESI+) calculated for C15H23O4INa [M+Na]+ 417.0539, found 417.0535. 
  
15
O
17
HO
O 10
IO
 27 
C10-C17 Aldehyde 3 
 
Dess-Martin Periodinane (250 mg, 583 µmol) was added to a stirred suspension of alcohol 16a (46.0 
mg, 117 µmol) and NaHCO3 (48 mg, 1.17 mmol) in wet CH2Cl2 (2 mL). The reaction mixture was 
stirred at r.t. for 30 min before quenching by the addition of NaHCO3 (2 mL) and Na2S2O3 solution (2 
mL) and stirred at r.t. for 30 min. The layers were separated, and the aqueous phase was extracted with 
CH2Cl2 (3 × 2 mL). The combined organic phases were dried (MgSO4) and concentrated under reduced 
pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 0%  5%) afforded the 
product 3 as a colourless oil (30.3 mg, 77.2 µmol, 86% brsm), alongside with 20-30% of the C10 
protodeiodinated product that is inseperable at this stage. 
Rf (EtOAc/PE 40-60: 20%) = 0.35; 1H NMR (500 MHz, CDCl3) dH 9.63 (1H, s, H17), 6.03 (1H, q, J = 1.1 
Hz, H10), 5.59 (1H, s, =CH), 5.19 (1H, dd, J = 6.4, 4.1 Hz, H15), 4.41 (1H, dt, J = 13.7, 6.6 Hz, H13), 
2.70 (1H, dd, J = 14.0, 6.7 Hz, H12a), 2.55 (1H, ddd, J = 13.7, 7.2, 6.4 Hz, H14a), 2.50 (1H, dd, J = 14.0, 
6.4 Hz, H12b), 2.15 (3H, d, J = 1.3 Hz, =CMeaMeb), 1.90 (6H, s, Me11, =CMeaMeb), 1.79 (1H, ddd, J = 
13.7, 6.2, 4.1 Hz, H14b), 1.31 (3H, s, Me16); 13C NMR (125 MHz, CDCl3) dC 201.0, 165.1, 159.3, 144.4, 
114.9, 87.6, 79.7, 77.6, 76.8, 45.9, 37.7, 27.5, 24.4, 20.4, 19.6; IR (thin film): νmax 2918, 1738, 1723, 1649, 
1443, 1377, 1224, 1138, 1076; [α]D
20  –3.4 (c 0.29, CHCl3); HRMS (ESI+) calculated for C15H21IO4Na 
[M+Na]+ 415.0382, found 415.0373. 
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2.4. Vinylmetal addition and acetonide formation 
General procedure for the vinylmetal addition of vinyl iodide 2 to aldehyde 3 
tBuLi (13 eq., molarity in pentane titrated before use) was added dropwise (down the side of the flask) 
to a stirred solution of vinyl iodide 2 or ent-2 (6.5 eq., dried by azeotroping with PhH and over CaH2) 
in Et2O (0.1 M relative to vinyl iodide) at –78 °C, taking care that the reaction temperature did not 
exceed –78 °C. The solution was stirred for 30 seconds before the dropwise addition of a freshly prepared 
solution of MgBr2·OEt2 (19 eq., 0.6 M in Et2O) into the reaction mixture at –78 °C. The mixture was 
stirred for 5 min at –78 °C before the dropwise addition of aldehyde 3 (1 eq., dried by azeotroping with 
PhH ´ 3) in CH2Cl2 (0.1 M relative to aldehyde) via cannula (down the side of the flask). The pale-
yellow reaction mixture was stirred at –78 °C for 1 h before quenching with NH4Cl (3 mL) and warmed 
to r.t.. The layers were separated, and the aqueous phase was extracted with CH2Cl2. The combined 
organic phases were dried (MgSO4) and concentrated under reduced pressure. Purification by flash 
column chromatography (Et2O/PE 40-60: 0%  5%) afforded the crude product as a colourless oil as 
an inseparable mixture of diastereomers, alongside with their C10 protodeiodinated counterparts. The 
crude product mixture was subjected to the acetonide formation sequence outlined below. 
General procedure for the synthesis of diacetonides anti-19a, syn-19b and 21-epi-anti-19c 
PPTS (one crystal) was added to a stirred solution of bis-silyl ethers 17a, 17b or 17c (1 eq.) in CH2Cl2 
(100 µL) and methanol (100 µL) at r.t.. The reaction mixture was stirred for 16 h at r.t. before quenching 
with NaHCO3 and diluting with EtOAc. The layers were separated, and the aqueous phase was extracted 
with EtOAc. The combined organic phases were dried (MgSO4) and concentrated under reduced 
pressure. The crude triol was dissolved in MeOH (150 µL) and K2CO3 (6 mg, ca. 10 eq.) was added. The 
pale-yellow mixture was stirred overnight at r.t. before quenching with NH4Cl and diluted with EtOAc. 
The layers were separated, and the aqueous phase was extracted with EtOAc. The combined organic 
phases were dried (MgSO4) and concentrated under reduced pressure. The crude tetraol was redissolved 
in CH2Cl2 (100 µL) and 2,2-dimethoxypropane (100 µL) and PPTS (one crystal) was added. The 
solution was stirred for a further 16 h before quenching with NaHCO3 and diluting with EtOAc. The 
layers were separated, and the aqueous phase was extracted with EtOAc. The combined organic phases 
were dried (MgSO4) and concentrated under reduced pressure. Purification by preparative thin layer 
chromatography (EtOAc/PE 40-60: 20%) afforded the diacetonide as a colourless oil. 
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Alcohol 17a and 15,17-anti acetonide anti-19a 
    
The addition reaction was performed according to the general procedure described above, using vinyl 
iodide 2 (42.0 mg, 88.9 µmol), tBuLi (120 µL, 185 µmol, 1.5 M in pentane), MgBr2·OEt2 (381 µL, 229 
µmol, 0.6 M solution in Et2O), and aldehyde 3 (4.9 mg, 12.7 µmol) to afford the crude product 17a (7.2 
mg, 9.78 µmol, 77%), a colourless oil as an inseparable 5 : 1 mixture of diastereomers at C17. alongside 
with the C10 protodeiodinated material. 
The crude product was transformed to the corresponding acetonide anti-19a according to the general 
procedure described above to afford the pure diacetonide anti-19a as a colourless oil (1.3 mg, 2.37 mmol, 
24% over three steps) 
Rf (EtOAc/PE 40-60: 20%) = 0.85; 1H NMR (500 MHz, CDCl3) dH 5.97 (1H, q, J = 0.9 Hz, H10), 5.19 
(1H, dq, J = 8.6, 1.0 Hz, H18), 4.40 (1H, d, J = 8.6 Hz, H17), 4.21-4.14 (1H, m, H13), 3.94 (1H, dd, J = 
7.0, 2.1 Hz, H15), 3.64 (1H, dd, J = 9.0, 2.7 Hz, H21), 3.61 (1H, d, J = 11.4 Hz, H23a), 3.28 (1H, d, J = 
11.4 Hz, H23b), 2.63 (1H, dd, J = 13.9, 7.7 Hz, H12a), 2.48 (1H, dd, J = 13.9, 5.5 Hz, H12b), 2.32 (1H, 
app dt, J = 13.9, 7.0 Hz, H14a), 2.11-2.01 (2H, m, H20), 1.85 (3H, d, J = 0.9 Hz, Me11), 1.73-1.65 (4H, 
m, H14b, Me19), 1.39 (3H, s, MeAMeBCO(O))A, 1.38 (3H, s, MeAMeBCO(O))B, 1.36 (3H, s, 
MeAMeBCO(O))B, 1.34 (3H, s, MeAMeBCO(O))A, 1.06 (3H, s, Me16), 1.01 (3H, s, Me22a), 0.74 (3H, s, 
Me22b); 13C NMR (125 MHz, CDCl3) dC 145.3, 137.6, 123.0, 100.3A, 98.6B, 87.0, 77.7, 76.6, 76.1, 75.5, 
72.2, 72.1, 46.4, 39.9, 38.7, 36.7, 32.9, 29.7B, 25.4A, 24.2, 23.8A, 21.8, 18.9B, 18.5, 18.0, 17.8; IR (thin film): 
νmax 2925, 1460, 1375, 1223, 1100; [α]D
20 +19.5 (c 0.06, CHCl3); HRMS (ESI+) calculated for C25H41O5IH 
[M+H]+ 549.2077, found 549.2082. 
ASignals attributed to the C15,C17 acetonide BSignals attributed to the C21,C23 acetonide 
The 15,17-anti configuration in anti-19a was confirmed firstly by observing the 13C chemical shifts for 
the acetonide Me (25.4 and 23.8 ppm) and acetal centre (100.3 ppm), both of which were strongly 
indicative for the 15,17-anti stereochemistry adopted as a result of the twist-boat conformation of the 
acetonide, placing the two acetonide Me groups in a pseudo equivalent chemical environment (Figure 
S4).9 This was corroborated by running a series of NOE experiments. Notably: 
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1) No NOE correlation was observed between Me16 and H17, indicating a trans relationship between 
Me16 and H17 
2) H15 show strong NOE enhancements to Me16 and one of the acetonide Me, while H17 shows a 
strong NOE enhancement to the other acetonide Me, indicating that H15 and Me16 sit on one side 
of the acetonide, while H17 sits on the other. This places H15 and H17 trans to each other in this 
ring, and therefore a 15,17-anti relationship exists between them 
 
 
Figure S4. Observed NOE correlations for anti-19a. Irradiated signals are denoted in orange, while observed NOE correlations 
from the irradiated signals are denoted in grey  
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Alcohol 17b and 15,17-syn acetonide syn-19b 
 
   
The addition reaction was performed according to the general procedure described above except 
omitting the addition of MgBr2OEt2, using vinyl iodide 2 (42.0 mg, 88.9 µmol), tBuLi (97 µL, 185 µmol, 
1.9 M in pentane), and aldehyde 3 (4.9 mg, 12.7 µmol) to afford the crude product 17b (3.5 mg, 4.74 
µmol, 37%), a colourless oil as an inseperable 4 : 1 mixture of diastereomers at C17, alongside with the 
C10 protodeiodinated material. 
The crude product was transformed to the corresponding acetonide syn-19b according to the general 
procedure described above to afford the pure diacetonide as a colourless oil (1.8 mg, 3.28 mmol, 69% 
over three steps). Owing to competing lithium/iodine exchange at C10 from the formed vinyllithium 
species in the previous step, the product acetonide contains a 1 : 1 mixture of the C10 protodeiodinated 
species that was inseparable. 
Rf (EtOAc/PE 40-60: 20%) = 0.87; 1H NMR (500 MHz, CDCl3) dH 5.98 (1H, s, H10), 5.55 (1H, d, J = 8.6 
Hz, H18), 4.50 (1H, d, J = 8.6 Hz, H17), 4.22-4.19 (1H, m, H13), 4.11 (1H, app d, J = 4.5 Hz, H15), 3.81 
(1H, dd, J = 7.0, 2.2 Hz, H21), 3.66 (1H, d, J = 11.6 Hz, H23a), 3.27 (1H, d, J = 11.5 Hz, H23b), 2.73 (1H, 
dd, J = 13.5, 7.8 Hz, H12a), 2.44 (1H, dd, J = 13.5, 5.8 Hz, H12b), 2.38-2.30 (1H, m, H14a), 2.25 (1H, dd, 
J = 15.5 Hz, 7.0 Hz, H20a), 1.98-1.93 (1H, m, H20b), 1.88 (3H, d, J = 1.0 Hz, Me11), 1.76 (3H, s, Me19), 
1.74-1.66 (1H, m, H14b), 1.49 (3H, s, MeAMeBCO(O))A, 1.42 (3H, s, MeAMeBCO(O))A, 1.42 (3H, s, 
MeAMeBCO(O))B,  1.37 (3H, s, MeAMeBCO(O))B, 1.03 (3H, s, Me22a), 0.93 (3H, s, Me16), 0.74 (3H, s, 
Me22b); 13C NMR (125 MHz, CDCl3) dC 145.6, 140.2, 121.3, 98.5B, 97.4A, 78.8, 77.0, 76.9, 75.3, 74.5, 72.3, 
69.7, 46.8, 38.5, 36.9, 32.9, 30.0A, 29.9B, 24.4, 21.8, 20.6, 19.2A, 19.0, 18.8B, 18.1; IR (thin film): νmax 2928, 
1464, 1377, 1261, 1129, 1098; [α]D
20  +17.9 (c 0.08, CHCl3); HRMS (ESI+) calculated for C25H41O5IH 
[M+H]+ 549.2077, found 549.2078. 
ASignals attributed to the C15,C17 acetonide BSignals attributed to the C21,C23 acetonide 
The 15,17-syn configuration in syn-19b was confirmed firstly by observing the 13C chemical shifts for 
the acetonide Me (19.2 and 30.0 ppm) and acetal centre (97.4 ppm), both of which were strongly 
indicative for the 15,17-syn stereochemistry adopted as a result of the chair conformation of the 
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acetonide, placing the two acetonide Me groups in different chemical environments (Figure S5).9 This 
was corroborated by running a series of NOE experiments. Notably, strong NOE enhancements were 
shown between one of the acetonide Me with all of H15, Me16 and H17, signifying that all three 
substituents are sitting on the same side of the ring (the other acetonide Me does not show any NOE 
enhancements to H15, Me16 or H17). This observation places H15 and H17 cis to each other in the ring, 
and therefore a 15,17-syn relationship exists between them 
 
 
Figure S5. Observed NOE correlations for syn-19b. Irradiated signals are denoted in orange, while observed NOE correlations 
from the irradiated signals are denoted in grey 
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Proof of 17S configuration in 17b 
 
The assigned configuration at C17 was confirmed by forming the diastereomeric MTPA esters of 
alcohol 17b described below: DCC (15 µL, 14.9 µmol, 1 M in CH2Cl2) was added dropwise to a stirred 
solution of alcohol 17b (2.75 mg, 3.73 µmol), (R) or (S)-MTPA (3.5 mg, 14.9 µmol) and DMAP (one 
crystal) in CH2Cl2 (50 µL). The reaction mixture was stirred at r.t. for 16 h before filtering through a 
pad of silica1 The crude product was dissolved in MeOH (25 µL) and CH2Cl2 (25 µL) and PPTS (one 
crystal) was added. The solution was stirred at r.t. for 24 h before quenching with NaHCO3 (one drop), 
dried (MgSO4), filtered and the solvent removed under reduced pressure to afford the crude (S)-MTPA 
ester diols [(S)-MTPA-17b, 1.0 mg, 1.30 mmol, 46% over two steps] or crude (R)-MTPA ester diols 
[(R)-MTPA-17b, 1.0 mg, 1.30 mmol, 46% over two steps] as a colourless oil, which was analysed without 
further purification.  
(S)-MTPA-17b 
Rf (EtOAc/PE 40-60: 20%) = 0.25; 1H NMR (500 MHz, CDCl3) dH 5.81 (1H, d, J = 10.0 Hz, H17), 5.79 
(1H, s, H10), 5.66 (1H, s, =CH), 5.14 (1H, d, J = 10.0 Hz, H18), 5.04 (1H, dd, J = 7.0, 5.8 Hz, H15), 4.40 
(1H, d, J = 10.8 Hz, H23a), 4.18 (1H, m, H13), 4.01 (1H, d, J = 10.8 Hz, H23b), 3.48 (1H, m, H21), 2.43 
(1H, m, H14a), 2.41 (1H, m, H12a), 2.26 (1H, m, H12b), 2.19 (3H, s, =CMeaMeb), 2.11 (1H, m, H20a), 
1.94 (1H, m, H20b), 1.93 (3H, s, =CMeaMeb), 1.82 (3H, s, Me11), 1.75 (3H, s, Me19), 1.65 (1H, m, H14b), 
1.17 (3H, s, Me16), 0.92 (3H, s, Me22a), 0.88 (3H, s, Me22b) 
 (R)-MTPA-17b 
Rf (EtOAc/PE 40-60: 20%) = 0.22; 1H NMR (500 MHz, CDCl3) dH 5.88 (1H, s, H10), 5.73 (2H, m, =CH, 
H17), 5.33 (1H, s, H18), 4.95 (1H, dd, J = 7.8, 7.0 Hz, H15), 4.29 (1H, d, J = 10.4 Hz, H23a), 4.09 (1H, d, 
J = 10.4 Hz, H23b), 4.09 (1H, m, H13), 3.53 (1H, m, H21), 2.51 (1H, m, H12a), 2.32 (1H, m, H12b), 2.21 
                                                             
1 Analysis of the MTPA esters at this stage gave inconclusive results  
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(3H, s, =CMeaMeb), 2.17 (1H, m, H20a), 2.13 (1H, m, H14a), 1.98 (3H, s, =CMeaMeb), 1.97 (1H, H20b), 
1.81 (3H, s, Me11), 1.76 (3H, s, Me19), 1.14 (3H, s, Me16), 1.10 (1H, m, H14b), 0.92 (3H, s, Me22a), 
0.88 (3H, s, Me22b). 
Following the advanced Mosher model described by Hoye et al.,7 the C17 stereocentre was assigned as 
S as anticipated from the polar Felkin-Anh controlled addition of the vinyl lithium to aldehyde 3 via 
TS-III in Figure S6. 
Table S3. Diagnostic 1H NMR signals for the configurational assignment of 17S 
Proton dH (S)-MTPA-17b dH (R)-MTPA-17b Dd = dS – dR 
H13 4.18 4.09 +0.09 
H14A 2.43 2.13 +0.30 
H14B 1.65 1.10 +0.55 
H15 5.04 4.95 +0.09 
Me16 1.17 1.14 +0.03 
H17 5.81 5.73 +0.08 
H18 5.14 5.33 -0.19 
Me19 1.75 1.76 -0.01 
H20A 2.11 2.17 -0.06 
H20B 1.94 1.97 -0.03 
H21 3.48 3.53 -0.03 
 
 
 
Figure S6. Stereochemical rationalisation of adduct 17b via the Polar Felkin-Anh model 
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 35 
Alcohol 17c and 21-epi-anti acetonide 21-epi-anti-19c 
   
The addition reaction was performed according to the general procedure described above, using vinyl 
iodide ent-2 (42.0 mg, 88.9 µmol), tBuLi (97 µL, 185 µmol, 1.9 M in pentane), MgBr2·OEt2 (381 µL, 229 
µmol, 0.6 M solution in Et2O), and aldehyde 3 (4.9 mg, 12.7 µmol) to afford the crude product 17c (5.0 
mg, 6.78 µmol, 53%), a colourless oil as an inseparable 5 : 1 mixture of diastereomers at C17, alongside 
with the C10 protodeiodinated material. 
The crude product was transformed to the corresponding acetonide 21-epi-anti-19c according to the 
general procedure described above to afford the pure diacetonide 21-epi-anti-19c as a colourless oil (1.8 
mg, 3.28 mmol, 48% over three steps) 
Rf (EtOAc/PE 40-60: 20%) = 0.83; 1H NMR (500 MHz, CDCl3) dH 5.98 (1H, q, J = 0.8 Hz, H10), 5.19 
(1H, dq, J = 8.6, 1.2 Hz, H18), 4.42 (1H, d, J = 8.6 Hz, H17), 4.22-4.16 (1H, m, H13), 3.95 (1H, dd, J = 
6.9, 1.9 Hz, H15), 3.77 (1H, dd, J = 9.2, 2.4 Hz, H21), 3.62 (1H, d, J = 11.4 Hz, H23a), 3.27 (1H, d, J = 
11.4 Hz, H23b), 2.64 (1H, dd, J = 13.8, 7.8 Hz, H12a), 2.49 (1H, dd, J = 13.9, 6.2 Hz, H12b), 2.33 (1H, 
app dt, J = 14.0, 6.2 Hz, H14a), 2.21-2.18 (1H, m, H20a), 2.03-1.97 (1H, m, H20b), 1.86 (3H, d, J = 0.9 
Hz, Me11), 1.76 (3H, d, J = 1.0 Hz, Me19), 1.75-1.68 (1H, m, H14b), 1.42 (3H, s, MeAMeBCO(O))B, 1.39 
(3H, s, MeAMeBCO(O))A, 1.38 (3H, s, MeAMeBCO(O))B, 1.35 (3H, s, MeAMeBCO(O))A, 1.07 (3H, s, 
Me16), 1.02 (3H, s, Me22a), 0.73 (3H, s, Me22b); 13C NMR (125 MHz, CDCl3) dC 145.3, 138.9, 120.7, 
100.4A, 98.5B, 86.9, 78.2, 76.9, 76.7, 76.1, 71.9, 71.0, 46.5, 39.4, 36.6, 32.9, 30.9, 29.8B, 25.3A, 24.2, 23.6A, 
18.8B, 18.7, 18.3, 18.1; IR (thin film): νmax 2928, 2857, 1465, 1377, 1222, 1090, 1021; [α]D
20 –22.9 (c 0.05, 
CHCl3); HRMS (ESI+) calculated for C25H41O5INa [M+Na]+ 571.1891, found 571.1885. 
ASignals attributed to the C15,C17 acetonide BSignals attributed to the C21,C23 acetonide 
The 15,17-anti configuration in 21-epi-anti-19c was confirmed firstly by observing the 13C chemical 
shifts for the acetonide Me (25.6 and 23.8 ppm) and acetal centre (100.4 ppm), both of which were 
strongly indicative for the 15,17-anti stereochemistry adopted as a result of the twist-boat conformation 
of the acetonide, placing the two acetonide Me groups in a pseudo equivalent chemical environment 
(Figure S7).9 This was corroborated by running a series of NOE experiments. Notably: 
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3) No NOE correlation was observed between Me16 and H17, indicating a trans relationship between 
Me16 and H17 
4) H15 show strong NOE enhancements to Me16 and one of the acetonide Me, while H17 shows a 
strong NOE enhancement to the other acetonide Me, indicating that H15 and Me16 sit on one side 
of the acetonide, while H17 sits on the other. This places H15 and H17 trans to each other in this 
ring, and therefore a 15,17-anti relationship exists between them 
 
 
Figure S7. Observed NOE correlations for 21-epi-anti-19c. Irradiated signals are denoted in orange, while observed NOE 
correlations from the irradiated signals are denoted in grey 
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2.5. Discussion on NMR data, comparisons and biogenetic data 
2.5.1. Analysis of J values and NOE data for the assignment of H17 
With contradicting information from our foregoing analysis of the diastereomeric acetonides vis-à-vis 
the data reported for phormidolide A triacetonide, we turned to the reported NOE, 3JCH and 3JHH to 
further ascertain the configuration at C17.1 Reanalysis of the reported NOE enhancements by taking 
into account all J values allowed us to conclude that C17 was misassigned. In particular, the reported 
conformer, while giving a geometry that takes into account all J values, places H18 and Me16 (C37 in 
isolation paper) too far away to observe a NOE enhancement (Table S4 and Figure S8). The alternative 
C17 epimer that takes into account all the reported J values positions H18 in a proximal geometry to 
Me16 (C37 in isolation paper), which accounts for the strong NOE correlation observed in the isolation 
paper. These observations, alongside with the interpretation of the data obtained from comparing  anti-
19a and syn-19b relative to phormidolide triacetonide 18 reinforce the proposed reassignment of C17 
from S (reported) to R. 
 
Table S4: Excerpt of the NOE and 3J data used for the assignment of C17 from the original isolation paper. The key strong NOE 
enhancement between Me16 (C37 in the original isolation paper) and H18 is highlighted in orange 
Atom # 13C (ppm) 1H (ppm) ROESY COSY (Hz) HSQMBC (Hz) 
13 76.7 4.48 12b, 14b, Me11, Me16 14a (0.0), 14b (ovlp), 12a 
(14.0), 12b (5.0) 
11 (<0.5), 16 (10.6) 
14 34.8 1.57 15 15 (0.0), 13 (0.0) 13 (<0.5), 12 (4.1) 
  2.33 13, 15, 2 15 (4.8), 13 (ovlp) 13 (<0.5), 12 (4.5) 
15 79.6 5.15 12a, 14a, 17 (st), Me16 (wk), 18 (wk) 14a (0.0), 14b (4.8) 17 (<0.5), Me16 (5.5) 
16 86.9 -    
17 69.7 4.70 Me19, 15 (st), Me16 (wk) 18 (9.0) 19 (3.7), 16 (5.6), 15 
(5.5), Me16 (5.0) 
18 127.0 5.40 Me16 (st), 20a, 15 (wk) 17 (9.0) 20 (6.0), 16 (0.8), Me19 
(10.0) 
19 137.4     
Me16 21.0 1.19 13, 17 (wk), 15, 18 (st)   
 
  
 38 
 
Figure S8: Diagramatic representation of the relevant conformer that enabled the assignment of C17, taking into account all 3J 
and NOE data observed for phormidolide A. (Left) The conformer used in the isolation paper to give the originally assigned 17S 
configuration. (Right) The conformer that gives the 17R configuration taking into account of the strong NOE observed 
 
2.5.2. Rationale for necessitating the reevaluation of C21 relative to C17 
In the isolation paper,1 the stereochemical information at C17 was relayed across the planar sp2 region 
(C18-C19) of the natural product. In the absence of a direct long-range correlation (e.g. NOE 
enhancement or multiple bond J values/correlations) between H/C17 and a diastereomeric proton on a 
sp3 centre (e.g. H20a or H20b), one cannot definitively conclude that the natural product sits in a 
particular conformer, as in this instance, rotating the conformer by 180° would have all the J values 
conform but result in the opposite relative configuration of H/C17 relative to H/C21. 
There were two instances where this occurred in the assignment of phormidolide A. The first instance 
relates to the assignment of the THF core relative to H/C7 on the macrolactone. Here, the stereogenic 
information on H/C7 was relayed across the planar sp2 C9-C11 diene unit, and onwards onto the 
H/C13-H/C16 THF moiety. Fortuitously, the alternative conformer (where the entire diene unit is 
rotated by 180°) would result in a geometry for C1-C7 protruding away from the THF that would be 
unacceptable for ring closure onto H/C15, leaving only one possible conformer for this planar sp2 region 
and therefore allowing a conclusive assignment of the THF moiety relative to H/C7 (Table S5 and Figure 
S9). 
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Table S5: Excerpt of the NOE and 3J data used for the assignment of C7 and C13 from the original isolation paper. Note that 
atom number 35 is the exocyclic methylene proton (=CH2 at C9), and atom 36 is the allylic methyl group appended to C11 
Atom # 13C (ppm) 1H (ppm) ROESY COSY (Hz) HSQMBC (Hz) 
7 73.1 4.05 6b, 8b, 5, =CH2 9b 8a (11.5), 8b (2.3), 6a (10.5), 
6b (4.0) 
9 (<0.5), 9 (<0.5) 
8 43.8 2.46 10 7 (11.5) 10 (2.0), =CH2 9 (3.5), 7 (ovlp), 6 (4.0) 
  1.81 7 7 (2.3) 10 (1.4), =CH2 9 (5.0), 7 (5.9), 6 (4.8) 
9 141.5     
10 132.4 5.28 14b, 8a, 4, 2  36 (8.1), 12 (7.1), =CH2 9 (6.5), 8 (4.7) 
11 133.4     
12 48.3 2.33  13 (14.0) 14 (<0.5), 10 (4.8), Me11 (5.5) 
  2.58 13, Me11 13 (5.0) 14 (<0.5), 10 (3.0), Me11 (2.8) 
13 76.7 4.48 12b, 14b, Me11, Me16 14a (0.0), 14b (ovlp), 12a 
(14.0), 12b (5.0) 
11 (<0.5), 16 (10.6) 
=CH2 9 133.8 4.76 Me3, Me11  10 (5.9), 8 (10.0) 
  4.98 7  10 (11.2), 8 (5.9) 
Me11 16.8 1.58 13, =CH2 9a  9, 10, 12 
 
 
 
Figure S9: Analysis of the two candidate conformers between H/C7 and H/C13 highlight the alternative (unconsidered) 
conformer would place the remainder of the chain too far away to enable ring closure, despite fitting all J value and NOE data 
The same conclusion cannot be obtained by relaying the stereochemical relationship from H/C17 across 
the planar sp2 region (C18-C19) onto H/C21. In this case, the side chain is linear and not constrained 
geometrically (compared to H/C7 where the macrocycle must close onto H/C15), and so two possible 
conformers can exist that fits all the observed J and NOE values (Table S6, Figure S10). As such, further 
investigation into the relative configuration between H/C17 and H/C21 was warranted. We 
optimistically hoped that despite the distal 1,5 nature between the two stereocentres, the conformational 
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constraints imposed by the acetonides would allow for the facile NMR determination of the correct 
diastereomer between anti-19a (possessing the reassigned 17R configuration but the reported 21R 
configuration) and 21-epi-anti-19c (possessing the reassigned 17R configuration as well as the epimeric 
21S configuration) (Figure S11) 
Table S6: Excerpt of the NOE and 3J data used for the assignment of C17 and C21 from the original isolation paper. Note that 
atom number 38 is Me19 in our assignment of phormidolide A 
Atom # 13C (ppm) 1H (ppm) ROESY COSY (Hz) HSQMBC (Hz) 
17 69.7 4.70 Me19 (st), 15 (st), Me16 (wk) 18 (9.0) 19 (3.7), 16 (5.6), 15 (5.5), Me16 (5.0) 
18 127.0 5.40 Me16 (st), 20a, 15 (wk) 17 (9.0) 20 (6.0), 16 (0.8), Me19 (10.0) 
19 137.4     
20 42.3 2.06 18, Me22a 21 (10.6) 22 (0.4), Me19 (6.3), 18 (6.5), 21 (2.0) 
  2.34 21, Me22b, Me19 21 (2.3) 18, 19 
21 77.5 3.65 20b, Me19, Me22b, 23 10a (10.6), 20b (2.4) 23 (2.0), Me22a, Me22b, 19 (3.5) 
Me19 17.3 1.80 21, 17 (st), 20b  18, 19, 20 
 
 
 
Figure S10: Analysis of the two candidate conformers between H/C17 and H/C21 highlight the equally probable (unconsidered) 
conformer that conforms to all the J values and NOE correlations observed for phormidolide A 
nOe correlations observed 3JCH coupling observed3JHH coupling observed
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Figure S11: Candidate diastereomers to evaluate the distal 1,5-related stereocentres in the natural product 
 
The remaining J based analysis for the side chain from H/C21 to H/C33 was conclusive, especially taking 
into account the reported preparation of the phormidolide A diacetonide derivative (with the acetonide 
bridging between OH21 and OH23, and a second acetonide bridging OH25 and OH27). As there exists 
unambiguous NOE data and J values from both the natural product as well as the acetonide derivative 
to corroborate the all syn substitution on the polyol side chain, a reassignment of H/C21 will by 
extension, result in the analogous reassignment of all remaining stereocentres present on the side chain. 
(For a detailed discussion of the assignment of the phormidolide A side chain, please refer to 
Williamson, R. T.; Boulanger, A.; Vulpanovici, A.; Roberts, M. A.; Gerwick, W. H. J. Org. Chem. 2002, 
67 (23), 7927–7936) 
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2.5.3. NMR comparisons between anti-19a, syn-19b and 21-epi-anti-19c with 18 
Table S7: Table of 1H NMR data of phormidolide A triacetonide 18 and diacetonides anti-19a, syn-19b and 19-epi-anti-19c 
 
 
 
Table S8: Table of 13C NMR data of phormidolide A triacetonide 18 and diacetonides anti-19a, syn-19b and 19-epi-anti-19c 
 
Phm A 
triacetonide 
anti-19a syn-19b 21-epi-anti-19c 
 
13C (ppm) 13C D |D| 13C D |D| 13C D |D| 
Ac1 23.7 23.8 0.10 0.10 20.5 -3.2 3.2 23.6 0.1 0.1 
Ac2 25.3 25.4 0.10 0.10 30.0 4.7 4.7 25.3 0.0 0.0 
C13 76.8 76.6 -0.20 0.20 74.5 -2.3 2.3 76.7 -0.1 0.1 
C14 36.7 36.7 0.00 0.00 36.9 0.2 0.2 36.6 -0.1 0.1 
C15 78.2 77.7 -0.50 0.50 75.3 -2.9 2.9 78.2 0.0 0.0 
C16 87.0 87.0 0.00 0.00 78.8 -8.2 8.2 86.9 -0.1 0.1 
Me16 18.4 18.9 0.50 0.50 19.2 0.8 0.8 18.7 0.3 0.3 
C17 71.8 73.0 1.20 1.20 70.0 -1.8 1.8 71.9 0.1 0.1 
C18 120.3 123.0 2.70 2.70 121.5 1.2 1.2 120.7 0.4 0.4 
Me19 18.2 17.8 -0.40 0.40 19.0 0.8 0.8 18.3 0.1 0.1 
C20 39.0 40.0 1.00 1.00 38.5 -0.5 0.5 39.4 0.4 0.4 
C21 77.6 76.1 -1.50 1.50 76.9 -0.7 0.7 76.1 -1.5 1.5 
 
Phm A 
triacetonide 
anti-19a 
  
syn-19b 21-epi-anti-19c 
 
 
1H (ppm) 1H D |D| 1H D |D| 1H D |D| 
Ac1 1.34 1.34 0.00 0.00 1.49 0.15 0.15 1.35 0.01 0.01 
Ac2 1.38 1.39 0.01 0.01 1.38 0.00 0.00 1.39 0.01 0.01 
H13* 4.16 4.17 0.01 0.01 4.11 -0.05 0.05 4.19 0.03 0.03 
H14A 2.32 2.32 0.00 0.00 2.34 0.02 0.02 2.33 0.01 0.01 
H14B 1.75 1.70 -0.05 0.05 1.72 -0.03 0.03 1.71 -0.04 0.04 
H15* 3.94 3.94 0.00 0.00 4.21 0.27 0.27 3.95 0.01 0.01 
Me16 1.07 1.06 -0.01 0.01 0.93 -0.14 0.14 1.07 0.00 0.00 
H17 4.42 4.40 -0.02 0.02 4.50 0.08 0.08 4.42 0.00 0.00 
H18 5.18 5.19 0.01 0.01 5.55 0.37 0.37 5.19 0.01 0.01 
Me19 1.74 1.72 -0.02 0.02 1.76 0.02 0.02 1.76 0.02 0.02 
H20A 2.20 2.09 -0.11 0.11 2.25 0.05 0.05 2.18 -0.02 0.02 
H20B 2.03 2.05 0.02 0.02 1.98 -0.05 0.05 2.03 0.00 0.00 
H21 3.70 3.64 -0.06 0.06 3.81 0.11 0.11 3.78 0.08 0.08 
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*In the paper that describes the formation of the phormidolide triacetonide derivative, the 1H values 
for H13 and H15 were erroneously swapped. A reexamination of their 2D 1H-1H COSY data as well as 
our NMR data supports this conclusion. Specifically, the signal attributed to dH 4.1x ppm couples to dH 
2.50 and 2.34 ppm (signals that are attributed to H12). This means the signal attributed to 4.1x ppm 
arises from H13, rather than H15. 
 
Figure S12: Bar chart showing 1H NMR shift differences of diacetonides anti-19a, syn-19b and 19-epi-anti-19c between H13-
H21 inclusive of acetonide protons. 
 
Figure S13: Bar chart showing 13C NMR shift differences of diacetonides anti-19a, syn-19b and 19-epi-anti-19c between C13-
C21 inclusive of acetonide carbons 
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Figure S14: Bar chart showing 1H NMR shift differences of anti-19a and 21-epi-anti-19c between H13-H21 inclusive of 
acetonide protons. The omission of syn-19 allows a better comparison between which of the two diastereomers is likely to be 
correct 
 
Figure S15: Bar chart showing 13C NMR shift differences of anti-19a and 21-epi-anti-19c between C13-C21 inclusive of 
acetonide protons. The omission of syn-19b allows a better comparison between which of the two diastereomers is likely to be 
correct 
 
-0.15
-0.1
-0.05
0
0.05
0.1
Ac1 Ac2 H13 H14A H14B H15 Me16 H17 H18 Me19 H20A H20B H21
D H
 (p
pm
)
anti-19 21-epi-anti-19
-2.00
-1.50
-1.00
-0.50
0.00
0.50
1.00
1.50
2.00
2.50
3.00
Ac1 Ac2 C13 C14 C15 C16 Me16 C17 C18 Me19 C20 C21
D C
 (p
pm
)
anti-19 21-epi-anti-19
 45 
 
Figure S16: Summary of diagnostic chemical shifts between phormidolide A triacetonide 18 and diacetonides anti-19a, syn-19b 
and 19-epi-anti-19c 
On comparing NMR shift errors with  phormidolide A triacetonide 18, syn-19b was immediately 
eliminated as a possible diastereomer due to the large deviations in the 15,17-acetonide region of the 
molecule, leaving anti-19a and 19-epi-anti 19c as the remaining candidates (see Figure S12, Figure S13).   
Of the two remaining diastereomers, 13C NMR correlations were particularly diagnostic for the 17,21-
syn relationship (leading to the 21R configuration), in particular with the large deviations observed in 
Me16, C17 and C18 (Figure S15). This allowed us to eliminate anti-19a as a candidate diastereomer, 
leaving 19-epi-anti-19c as the candidate with the best match for the triacetonide 18, which is reassigned 
as 18a as shown above in Figure S16. 
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2.5.4. Commentary on ketoreductase domains in the biosynthesis of phormidolide A 
In a subsequent account, a comprehensive study10 on the biosynthesis of phormidolide A was reported. 
Within the polyketide synthase for phormidolide A, there exists 10 ketoreductase enzymes responsible 
for catalysing the formation of secondary OH groups from carbonyls, and therefore set the absolute 
stereochemistry of each carbinol centre OH group present in phormidolide A. Ketoreductases in 
polyketide synthases are often categorised into one of two types; Type A ketoreductases and type B 
ketoreductases.11,12 Type A ketoreductases often contain a W residue near the active site and generally 
catalyse the formation of L-configured OH groups. Type B ketoreductases often contain a LDD1758 motif 
at the active site and will generally catalyse the formation of D-configured OH groups. In particular, the 
D1758 residue is particularly diagnostic for the generation of D-configured OH groups. 
The authors performed a sequence alignment of the 10 ketoreductases present in the phormidolide A 
polyketide synthase and highlighted that nine of the 10 ketoreductases present contain the D1758 motif 
(but not the LDD triad) (Figure S17A). As all the OHs present in phormidolide A are L configured 
(rather than the expected D configuration that arises from a type B-like ketoreductase), this prompted 
in a reevaluation of the absolute configuration of C7 by forming the diastereomeric MTPA esters of the 
phormidolide A triacetonide derivative, which was reported to corroborate the L configuration at C7 
(Figure S17B). As the remaining OHs were all L configured, yet the ketoreductase responsible for the 
L-OH configuration contained the D1758 residue (predictive of a D-OH), they concluded that the 
presence of the D1758 residue was not predictive of D-OH formation and, by extension, reasoned that 
the remaining D1758 containing ketoreductases would also catalyse L-OHs present in phormidolide A. 
In light of the ambiguous stereochemical assignment of C21 relative to C17 (see section 2.5.2), we did 
not see the analysis of the ketoreductase domains as a conclusive proof for the stereochemistry of 
phormidolide A, despite several published examples where ketoreductases possessing the D1758 residue 
can go on to catalyse the formation of L-OHs. Our reassignment of the hydroxyl-bearing stereocentres 
(C17, C21, C23, C25 and C29) leads to reassigning these L-OH configured stereocentres to the 
corresponding D-OH epimer. Notably, this reassignment is more concordant with the observation that 
D1758 containing/type B-like ketoreductases catalyse the formation of D-OHs (Figure S18), leaving OH7 
as the apparent singly anomalous L-OH formed by a D1758 containing ketoreductase (rather than all the 
ketoreductases being anomalous). 
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Figure S17: A) Excerpt of sequence alignment data from ref 2, highlighting the conserved D1758 residue that is nominally 
indicative for D-OH formation B) Structure of phormidolide A highlighting that all OHs in the natural product are L 
configured. This apparent contradiction was resolved by confirming the absolute stereochemistry at C7 (confirmed L) and 
extending the logic that the remaining stereocentres could also be L configured. 
 
Figure S18: Reassignment of C17-C29 of phormidolide A from 1 to 1a allows for greater alignment of the observed 
stereochemistry of the natural product to the proposed biosynthesis 
In light of our spectroscopic data from the model acetonides, reanalysis of the J- and NOE-based 
configurational analysis as well as the reported genetic data on the biosynthesis of phormidolide A, we 
believe that this configurational reassignment is fully supported. However, conclusive proof must await 
the completion of the total synthesis of structure 1a and comparison with natural phormidolide A.  
(For a detailed discussion on the biosynthesis of phormidolide A, please refer to Bertin, M. J.; 
Vulpanovici, A.; Monroe, E. A.; Korobeynikov, A.; Sherman, D. H.; Gerwick, L.; Gerwick, W. H. 
ChemBioChem 2016, 17 (2), 164–173) 
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2.7. NMR spectra for all new compounds 
See below for 1H and 13C spectra for all new compounds. For anti-19a, syn-19b (and Mosher derivatives 
of 17b) and 21-epi-anti-19c, 1H-1H COSY spectra are also provided. For anti-19a, syn-19b and 21-epi-
anti-19c, 1H-13C HSQC (edited) spectra are additionally provided. 
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